Chapter 57. Safety of Hepatitis B Vaccines

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. Arie J Zuckerman

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch57

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

Zuckerman, A. J. (2005) Safety of Hepatitis B Vaccines, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch57

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131

SEARCH

Keywords:

  • hepatitis B vaccines;
  • sudden infant death syndrome;
  • chronic fatigue syndrome;
  • demyelinating diseases;
  • immunization

Summary

This chapter contains sections titled:

  • Introduction

  • Hepatitis B vaccine and sudden infant death syndrome

  • Hepatitis B vaccine and chronic fatigue syndrome (post-viral fatigue syndrome or benign myalgic encephalomyelitis)

  • Hepatitis B vaccine, multiple sclerosis and other demyelinating diseases

  • Conclusions